tiprankstipranks
Trending News
More News >
OmniAb (OABI)
NASDAQ:OABI
US Market

Compare OmniAb (OABI) vs. Competitors

Compare
276 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
OmniAb
$1.82
$262.00M
-3.08
-43.30%
6 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$6.83
$177.60M
-0.13
-64.76%
6 Buy
2 Hold
0 Sell
Strong Buy
Tiziana Life Sciences
$1.37
$179.47M
-13.21
119.80%
Atea Pharmaceuticals
$4.24
$331.26M
-2.39
41.81%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$13.00
$284.84M
-0.03
-53.24%
6 Buy
1 Hold
0 Sell
Strong Buy
Sagimet Biosciences, Inc. Class A
$5.67
$175.78M
-3.17
39.66%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OABI
OmniAb
1.82
-1.38
-43.13%
RNAC
Cartesian Therapeutics
6.83
-13.06
-65.66%
TLSA
Tiziana Life Sciences
1.51
0.83
122.06%
AVIR
Atea Pharmaceuticals
4.24
1.32
45.21%
VOR
Vor Biopharma
13.00
-13.80
-51.49%
SGMT
Sagimet Biosciences, Inc. Class A
5.67
1.01
21.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts